Real-time enrollment status for this recurrent medulloblastoma clinical trial
Current Status
Recruiting
Checked: July 14, 2026 at 4:32 PM UTC
| NCT Number | NCT07698899 |
| Recruiting Status | Recruiting |
| Condition | Recurrent Medulloblastoma |
| Phase | PHASE1 |
| Target Enrollment | 18 participants |
| Active Locations | 7 sites in the US |
| Sponsor | Memorial Sloan Kettering Cancer Center |
| Last Updated on CT.gov | July 13, 2026 (Yesterday) |
As of July 14, 2026: Clinical trial NCT07698899 is currently recruiting participants. This phase1 study for recurrent medulloblastoma is actively seeking new participants at 7 locations across the United States. The study is sponsored by Memorial Sloan Kettering Cancer Center. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07698899 is actively recruiting participants as of July 14, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 7 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07698899 was last updated Yesterday (July 13, 2026). HelloStudys verifies this status automatically.